Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Ipamorelin 100–300 mcg CJC-1295 (No DAC) Frequency Multiple times daily Once daily Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy

This comparison does not assign a generated winner or score.

  • Dose Range
  • Ipamorelin
  • 100–300 mcg
  • CJC-1295 (No DAC)
  • Frequency
  • Multiple times daily
  • Once daily
  • Administration
  • Subcutaneous injection
  • Cycle Length
  • 8-12 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material

Comparison

CJC-1295 With DAC vs Without DAC

CJC-1295 with DAC and CJC-1295 without DAC differ mainly by the presence or absence of an albumin-binding Drug Affinity Complex [2] [3]. That difference changes how the peptide is…

View details →
Comparison

Quickcomparison

Dose Range Sermorelin 100–300 mcg CJC-1295 (No DAC) Frequency Once daily Administration Subcutaneous injection Cycle Length 12+ weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) E…

View details →